Apogee Therapeutics raises $323.3 million in public offering on Nasdaq
PositiveFinancial Markets

Apogee Therapeutics has successfully raised $323.3 million through a public offering on Nasdaq, marking a significant milestone for the company. This funding will enable Apogee to advance its innovative therapies and expand its research efforts, which is crucial for addressing unmet medical needs. The strong investor interest reflects confidence in Apogee's potential to make a meaningful impact in the biotech industry.
— Curated by the World Pulse Now AI Editorial System